As in the first part of our study investigating the effects of the first two vaccinations with BNT162b2 (6), IgA titers were significantly higher in COVID-19-convalescent compared with COVID-19-naïve individuals (16.1-fold before and 3.4-fold after third vaccination). Here, CD79A is linked to COVID-19.